HLA 30/8/21
Highlights of our FY21 results were:
- $140.4m revenue, +52% increase (FY20: $92.5m)
- $21.5m underlying EBITDA, +62% increase (FY20: $13.2m)
- $8.9m underlying NPATA, +91% increase (FY20: $4.6m)
- 9.1% organic growth (FY20: 5.3%)
- 212 allied health businesses, including +61 added in FY21
- Successful integration of The Optical Company, opening a $3.3 billion market opportunity for the new Eyes & Ears division
- Final fully franked dividend of 2.50 cents per share, bringing the total dividend for FY21 to 4.50 cents per share
I will be presenting these results in further detail at 10.00am AEST this morning at our online investor briefing which I welcome you to attend by clicking below to receive a link to join.
*Acquisition:
During the 2020 Financial Year, Healthia acquired 31 allied health businesses (18 Podiatry Clinics, 9 Physiotherapy Clinics and 4 Hand Therapy Clinics)
Disc' just researching this mob.